Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types
about
Laminin-411 is a vascular ligand for MCAM and facilitates TH17 cell entry into the CNSCloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3The biological functions of T helper 17 cell effector cytokines in inflammationStructure of IL-22 bound to its high-affinity IL-22R1 chainInterleukin-24 and its receptorsThe Innate Immune System in Acute and Chronic WoundsCrystal structure of interleukin-19 defines a new subfamily of helical cytokinesStructure and Mechanism of Receptor Sharing by the IL-10R2 Common ChainStructural basis for receptor sharing and activation by interleukin-20 receptor-2 (IL-20R2) binding cytokinesAnti-IL-20 monoclonal antibody inhibits the differentiation of osteoclasts and protects against osteoporotic bone lossToll-like receptor 2 and 4 induced interleukin-19 dampens immune reactions and associates inversely with spondyloarthritis disease activityThe T-cell lymphokine interleukin-26 targets epithelial cells through the interleukin-20 receptor 1 and interleukin-10 receptor 2 chainsInterleukin-19 mediates tissue damage in murine ischemic acute kidney injuryInhibiting interleukin-19 activity ameliorates esophageal squamous cell carcinoma progressionInterleukin-19: a constituent of the regulome that controls antigen presenting cells in the lungs and airway responses to microbial productsStructural mapping of post-translational modifications in human interleukin-24: role of N-linked glycosylation and disulfide bonds in secretion and activityRecombinant interleukin-24 lacks apoptosis-inducing properties in melanoma cells.The p38 MAPK regulates IL-24 expression by stabilization of the 3' UTR of IL-24 mRNA.Astrocytes produce IL-19 in response to bacterial challenge and are sensitive to the immunosuppressive effects of this IL-10 family member.mda-7 (IL-24) Mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK.Tumour suppressor function of MDA-7/IL-24 in human breast cancerEnhanced apoptosis-inducing function of MDA-7/IL-24 RGD mutant via the increased adhesion to tumor cells.Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions.Interleukin-26: an IL-10-related cytokine produced by Th17 cells.Structural analysis of cytokines comprising the IL-10 familyThe anti-inflammatory cytokine interleukin 19 is expressed by and angiogenic for human endothelial cells.IL-20: biological functions and clinical implications.Cytokine and cytokine receptor pleiotropy and redundancy.Kaposi's sarcoma-associated herpesvirus-encoded LANA down-regulates IL-22R1 expression through a cis-acting element within the promoter regionThe cationic cytokine IL-26 differentially modulates virus infection in culture.Comparative genomics identifies candidate genes for infectious salmon anemia (ISA) resistance in Atlantic salmon (Salmo salar)New activation modus of STAT3: a tyrosine-less region of the interleukin-22 receptor recruits STAT3 by interacting with its coiled-coil domainInterleukin-19 impairment in active Crohn's disease patients.IL-24 is expressed during wound repair and inhibits TGFalpha-induced migration and proliferation of keratinocytesThe colorectal tumor microenvironment: the next decade.Interleukin-19 acts as a negative autocrine regulator of activated microgliaSTAT3-Activating Cytokines: A Therapeutic Opportunity for Inflammatory Bowel Disease?mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokinePurification, crystallization and preliminary X-ray diffraction analysis of the IL-20-IL-20R1-IL-20R2 complex.First-In-Human, Phase 1, Randomized, Dose-Escalation Trial with Recombinant Anti-IL-20 Monoclonal Antibody in Patients with Psoriasis.
P2860
Q21090888-6CA42980-865C-4F3A-AB56-37899AA8805BQ24535580-DCFC2A44-30E1-43D9-8ECB-422618DCA304Q24614431-9AE4BA86-7C33-4330-A694-A03A28768316Q24656543-0F4DF361-C0F6-463C-9FE2-991C181E3A22Q24683032-0D161C97-A202-40EA-B19E-6271D445152FQ26767062-3FADC9F3-6681-410B-A12B-451D912AC032Q27639885-30D65EF2-0E30-4D17-97D3-C74E8A87CF5CQ27661538-5BCF02B0-173F-414E-B874-8CE13E0EC3A3Q27670756-39507B0C-EC45-447B-9BA0-66954A932851Q28245637-9EFCC51D-BE67-455C-B363-58A708C8F2C1Q28256275-A3F3AE3A-F719-402F-BD3A-FC7AAEBF06F3Q28265025-65CF42D9-821C-42A4-9EDF-23482B76AA75Q28508485-DDBB31E4-DDAD-4108-B065-CC6A56679366Q28534294-69AB51A0-9CD4-4BE3-AEC4-82693E788FA1Q28742709-63A922BE-FF13-4483-9A26-989504E1829BQ28749916-9EF86065-AE7B-433C-95A0-A8A0616418B0Q33309944-C2F96F00-5603-403F-A158-846014BA04F2Q33523814-E37ED558-A974-42A4-A0BC-D4831CB90238Q33827766-B08761A3-4BDE-42DF-9DEA-022EAD869A68Q34098956-D6ECC133-6120-4848-849B-5BBEBC93AB52Q34114046-E782F50B-DB5A-44C3-AAA7-5DDE2647640EQ34128541-64A95881-F53D-4D15-9D59-50323470DA6DQ34152063-4F500403-BCF3-4C7A-AD85-3730C9FC8D8AQ34384300-A4B32815-2982-450E-B725-DA7D79F8FCF8Q34384616-9B037237-0A85-47C1-8483-076D3C6642ACQ34420400-0E8FF3E8-E3AB-4BB1-9E8B-21177ED44ABEQ34526735-51B94AD1-9CC4-48F7-971B-ACBBE82B5B27Q34693494-21DD92C8-5B8F-4EA1-83E4-706DB212EA79Q34841987-31FE531A-F3DC-4748-A16E-3DB34A4AA707Q34854990-E6F99A92-1FC7-4F25-9884-6BE88B1F11C6Q34890770-78DAE72C-7DB7-4A1D-BDA8-0388AE5ABA76Q34994147-AA830EFC-6BCE-4FF5-B83C-94A420DBBB30Q35144211-E0FA4578-0549-4498-AED1-BEFD90836594Q35180316-3B6C2B12-A019-4D8A-8765-49669FF3FD33Q35206661-719BF8B6-23AD-45BD-930E-376F213DCBE9Q35582741-B1E814C5-EFC0-4A1A-8A63-10A4E3B4C781Q35589806-1D2B9B55-7E3A-41B3-9440-378586B801F4Q35609031-4C73D3D6-3A61-4484-B1A7-AE94E641C65DQ35660988-58C60B42-AC5D-4536-80BC-1A718230178AQ35739806-EEA11E1A-236F-4334-B5A4-99C2ECF0B6BE
P2860
Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types
description
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2001
@ast
im Oktober 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2001/10/01)
@sk
vědecký článek publikovaný v roce 2001
@cs
wetenschappelijk artikel (gepubliceerd op 2001/10/01)
@nl
наукова стаття, опублікована в жовтні 2001
@uk
مقالة علمية (نشرت في أكتوبر 2001)
@ar
name
Cutting edge: STAT activation ...... eceptor complexes of two types
@ast
Cutting edge: STAT activation ...... eceptor complexes of two types
@en
Cutting edge: STAT activation ...... eceptor complexes of two types
@nl
type
label
Cutting edge: STAT activation ...... eceptor complexes of two types
@ast
Cutting edge: STAT activation ...... eceptor complexes of two types
@en
Cutting edge: STAT activation ...... eceptor complexes of two types
@nl
prefLabel
Cutting edge: STAT activation ...... eceptor complexes of two types
@ast
Cutting edge: STAT activation ...... eceptor complexes of two types
@en
Cutting edge: STAT activation ...... eceptor complexes of two types
@nl
P2093
P3181
P1476
Cutting edge: STAT activation ...... eceptor complexes of two types
@en
P2093
C. Leemans
D. Lejeune
J. C. Renauld
L. Dumoutier
S. V. Kotenko
P304
P3181
P356
10.4049/JIMMUNOL.167.7.3545
P407
P577
2001-10-01T00:00:00Z